General Announcement::Announcement by TMC Life Sciences Berhad - Q2 2024 results announcement

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MED S$120M5.5%N280531 - SGXF52537366 - V2AB
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
02-Feb-2024 18:03:59
Status
New
Announcement Sub Title
Announcement by TMC Life Sciences Berhad - Q2 2024 results announcement
Announcement Reference
SG240202OTHR8Q8P
Submitted By (Co./ Ind. Name)
Dr Heng Jun Li Melvin
Designation
Executive Director and Group CEO
Description (Please provide a detailed description of the event in the box below)
Pls refer to the attached.

Attachments

TMCLS announcement_Q2 2024-Dec 23.pdf
Total size =275K